Revvity RVTY
NYSE RVTY
$150.76 -1.88 (-1.23%)
As of: Oct 19, 2026 · 3:59 PM EDT

Revvity (RVTY) Sale and Maturity of Investments (2023 - 2026)

Updated

Analysis

Revvity (RVTY) Sale and Maturity of Investments (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Thermo Fisher Scientific 251.93 Bn 230.96 Bn 4.88 Bn 3.00 Mn
2 Abbott Laboratories 181.29 Bn 151.72 Bn 7.27 Bn -
3 Danaher 158.18 Bn 141.99 Bn 3.61 Bn -
4 Intuitive Surgical 153.47 Bn 132.89 Bn 1.96 Bn 523.70 Mn
5 Medtronic 118.97 Bn 84.22 Bn 6.34 Bn 2.21 Bn
6 Stryker 114.72 Bn 100.84 Bn 4.50 Bn 16.00 Mn
7 Boston Scientific 66.18 Bn 60.95 Bn 3.85 Bn -
8 Becton Dickinson 52.49 Bn 49.64 Bn 2.32 Bn -
9 Edwards Lifesciences 50.32 Bn 34.33 Bn 1.35 Bn 448.50 Mn
10 Revvity 16.87 Bn 13.14 Bn 416.87 Mn 6.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 6.82 Mn
Apr 5, 2026 677,000.00
Dec 29, 2024 -2.50 Mn
Sep 29, 2024 712.50 Mn
Oct 1, 2023 450.00 Mn
API Access

Revvity Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=RVTY&period=max&api_key=YOUR_API_KEY